Find News

Filter articles

Applied Filters

Showing 111 to 120 of 127 results

Gilead’s attempt to patent Sovaldi in India opposed

India, US26-03-2014

Gilead Sciences has received another challenge to its application to patent its new hepatitis C drug Sovaldi (sofosbuvir) in India.

Vaccine maker KAEL-GemVax appoints CPA Global as IP specialist

South Korea13-03-2014

South Korean cancer vaccine maker KAEL-GemVax has appointed CPA Global as its IP management specialist.

Pfizer Australia faces antitrust accusations


Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies.

Australian High Court says medical treatment methods are patentable


The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention.

Takeda announces new COO


Takeda has announced that Christophe Weber, a member of GlaxoSmithKline’s global corporate executive team, will be joining the company as chief operating officer by April next year.

US reveals changes in TPP drug policy


The US government has said it is now advocating a “differential” approach to policies on patenting drugs as part of continuing trade negotiations with Pacific countries.

Japan and India to launch new research centres

Japan, US25-09-2013

A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students.

AIPPI 2013: Pharmaceutical products and the trademark hiccup


The annual International Association for the Protection of Intellectual Property conference in Helsinki has been assessing the potential problems for pharmaceutical companies trying to brand their medicinal products.

BioEconomy Academy launches in Bangkok


Law firm Rouse has teamed up with two organisations to open the BioEconomy Academy, an initiative aimed at boosting IP use and awareness in Thailand.

IPAB throws out Indian Vega trademarks


The Intellectual Property Appellate Board in Chennai has cancelled two trademarks associated with versions of Viagra.

Showing 111 to 120 of 127 results